Companies · Other Health Care

Gaia Herbs Inc

BREVARD · Other Health Care

Diligence memoA one-page analyst read on Gaia Herbs Inc — recommendation, valuation, rhythm, risks.
$67.9M
Total raised · real
5
Rounds
0.1×
Latest step-up
Top 7%
Sector rank · raised
Series C
Latest stage · inferred · Thu Jul 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Gaia Herbs Inc looks under-valued against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.10× the median modeled value of Series C Other Health Care companies in 2022–2024 (47 peers) — value vs value, same stage and era.
At-risk
  • Last raise 4.0 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Gaia Herbs Inc is one of 5377 Other Health Care companies tracked from BREVARD. By capital raised it ranks among the largest (ahead of 94% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
4
Investors (latest)
2022-07-07
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BPre-Seed · 2010-02-22 Raised $700K (real) Modeled valuation $22M (est)$700K$22MPre-Seed2010Pre-Seed · 2011-02-23 Raised $1.0M (real) Modeled valuation $31M (est)$1.0M$31MPre-Seed2011Series B · 2016-01-27 Raised $21M (real) Modeled valuation $462M (est)$21M$462MSeries B2016Series C · 2019-01-31 Raised $40M (real) Modeled valuation $922M (est)$40M$922MSeries C2019Series C · 2022-07-07 Raised $5.0M (real) Modeled valuation $68M (est)$5.0M$68MSeries C2022+$1.0M+$21M+$40M+$5.0MCumulative $68M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$700K · 2010
Pre-Seed extension$1.0M · 2011
Series B$20.9M · 2016no Seed / Series A on file
Series C$40.3M · 2019
Series C extension$5.0M · 2022

Stages are modeled from round size (public records carry no series label). No record for: Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 60%.

Modeled valuation trajectory
$68.1M
Base estimate est.
$18.2M
Conservative case
$136.0M
Upside case
$33.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $21.6M · 2010-02-222010Pre-Seed · modeled $30.8M · 2011-02-23Series B · modeled $462.3M · 2016-01-27Series C · modeled $922.4M · 2019-01-31Series C · modeled $68.1M · 2022-07-072022
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.29×/yr
Annual markup
1.48×/yr upside case
4.0 yr
Elapsed time used
4.0 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
37 mo
Avg between rounds
$5.5M/yr
Capital velocity
16.4 yr
On record since
2010
First round
5
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 28× above median
This company$67.9M
Sector median$2.4M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.1× of median
This company$5.0M
Sector median$45.9M
Modeled value — vs sector median (estimate, all stages) 3.1× above median
This company$68.1M
Sector median$22.1M

Raised more than 94% of sector peers (real $). Modeled value above 72% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #44 of 47.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Gravie, Inc. · Series C Raised $160.7M · modeled $1.3B (est)EmpowerMe Holdings, LLC · Series C Raised $96.6M · modeled $1.3B (est)Color Holdings, L.P. · Series C Raised $90.9M · modeled $1.1B (est)RSR Senior Residences, LLC · Series C Raised $73.7M · modeled $1.1B (est)Gynesonics, Inc · Series C Raised $299.1M · modeled $1.0B (est)Hello Heart Inc. · Series C Raised $127.0M · modeled $1.0B (est)Beta Bionics, Inc · Series C Raised $277.5M · modeled $1.0B (est)BioDerm Holdings, LP · Series C Raised $130.9M · modeled $1.0B (est)Kindbody, Inc. · Series C Raised $95.6M · modeled $875.1M (est)Drconsulta Ltd. · Series C Raised $140.1M · modeled $837.3M (est)Fountain Life, LLC · Series C Raised $103.9M · modeled $828.2M (est)TherapyMatch, Inc. · Series C Raised $100.0M · modeled $809.2M (est)Gaia Herbs Inc (this company) Raised $67.9M · modeled $68.1M (est)Gaia Herbs Inc
CompanyStageRaised · realValue · estvs peer med.
Gravie, Inc.Series C$160.7M$1.3B2.04×
EmpowerMe Holdings, LLCSeries C$96.6M$1.3B1.92×
Color Holdings, L.P.Series C$90.9M$1.1B1.75×
RSR Senior Residences, LLCSeries C$73.7M$1.1B1.71×
Gynesonics, IncSeries C$299.1M$1.0B1.58×
Hello Heart Inc.Series C$127.0M$1.0B1.54×
Beta Bionics, IncSeries C$277.5M$1.0B1.54×
BioDerm Holdings, LPSeries C$130.9M$1.0B1.53×
Kindbody, Inc.Series C$95.6M$875.1M1.33×
Drconsulta Ltd.Series C$140.1M$837.3M1.28×
Fountain Life, LLCSeries C$103.9M$828.2M1.26×
TherapyMatch, Inc.Series C$100.0M$809.2M1.23×
Gaia Herbs Inc this companySeries C$67.9M$68.1M0.10×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$700K2010-02-22$3.9M$21.6M85%
Pre-Seed$1.0M2011-02-23$5.6M$30.8M85%
Series B$20.9M2016-01-27$115.9M$462.3M85%
Series C$40.3M2019-01-31$269.0M$922.4M90%
Series C$5.0M2022-07-07$33.3M$68.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$700K2010-02-22
    • First recorded raise — entered as Pre-Seed.
    • 1 investor on this round.
  2. Pre-Seed$1.0M2011-02-23
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 1.4× larger than the prior — scaling up.
    • 1 investor on this round.
  3. Series B$20.9M2016-01-27
    • Raised again after 59 mo — slower than the ~14 mo sector norm.
    • Round 20.9× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 10 investors on this round.
  4. Series C$40.3M2019-01-31
    • Raised again after 36 mo — slower than the ~14 mo sector norm.
    • Round 1.9× larger than the prior — scaling up.
    • 1 investor on this round.
  5. Series C$5.0M2022-07-07
    • Raised again after 41 mo — slower than the ~14 mo sector norm.
    • Round 8.1× smaller than the prior — bridge or down round.
    • 4 investors on this round.
Intelligence
2025 ~Q3
Modeled next raise · ~37mo cadence
$5.0M
Modeled next size est.range $5.0M$8.0M
0.1×
Last step-up
$5.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
John Replogle5 other2022-07
Caroline MacGill2 other2019-01
Joe Glorfield2 other2010-02
Mark Finser2 other2010-02
Alexandra Lunt1 other2022-07
Angela McElwee1 other2019-01
Jasper Van Brakel1 other2019-01
John McKinney1 other2010-02
Mark Etson Finser1 other2016-01
Richard Scalzo1 other2010-02
Shahid Hassan1 other2022-07
Angela Etson McElwee2016-01
Bill Cave2019-01
James Geikie2022-07
J. Etson Brandenburg2011-02
Karen Domanski2010-02
Kyle Bliffert2022-07
Larry Etson Lunt2016-01
Larry Lunt2022-07
Registry & provenance

Gaia Herbs Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1443120
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
CRES Holdings, Inc.Other Health CareSeries C$61.1M$67.0Msame sector · same stage
Zarbee's, IncOther Health CareSeries B$43.8M$375.5Mnetwork1 shared operator · same sector
Merge Healthcare IncOther Health CareSeries C$45.3M$81.5Msame sector · same stage
ECP Manco, LLCOther Health CareSeries C$105.1M$78.4Msame sector · same stage
CodaMetrix Inc.Other Health CareSeries C$106.0M$77.7Msame sector · same stage
ReShape Lifesciences Inc.Other Health CareSeries C$113.8M$63.9Msame sector · same stage
Teton Waters Ranch LlcOtherSeries A$37.9M$45.4Mnetwork2 shared operators
Ablative Solutions, Inc.Other Health CareSeries C$180.2M$59.8Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
MedVirginia, Inc.Other Health CareSeed$12.4M86%
Gabbi, Inc.Other Health CarePre-Seed$18.9M86%
Cardia, Inc.Other Health CareSeed$9.0M84%
Gatc Canna CorpOther Health CarePre-Seed$15.4M84%
Luminopia, Inc.Other Health CareSeries B$142.2M84%
Georgia Medicinal Partners, LLCOther Health CarePre-Seed$2.2M84%
Hygieia IncOther Health CareSeries A$26.6M83%
Giogi Inc.Other Health CareSeed$30.5M83%
Frequently asked
How much funding has Gaia Herbs Inc raised?
Gaia Herbs Inc has raised approximately $67.9M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Gaia Herbs Inc's estimated valuation?
Provath's modeled valuation for Gaia Herbs Inc is approximately $68.1M (modeled range $18.2M–$136.0M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Gaia Herbs Inc at?
Gaia Herbs Inc's latest modeled financing stage is Series C. Its most recent recorded round closed around Thu Jul 07.
What does Gaia Herbs Inc do and where is it based?
Gaia Herbs Inc operates in the Other Health Care sector, based in BREVARD.
Explore related

See where Gaia Herbs Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Gaia Herbs Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.